AGPAT1
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha
Also known as: LPAAT-alpha, LPLAT1, PLCA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99943
- Gene
- AGPAT1
- Ensembl
- ENSG00000204310
- Chromosome
- 6
- Canonical length
- 283 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Rods & Rings
OverviewNCBI Gene
This gene encodes an enzyme that converts lysophosphatidic acid (LPA) into phosphatidic acid (PA). LPA and PA are two phospholipids involved in signal transduction and in lipid biosynthesis in cells. This enzyme localizes to the endoplasmic reticulum. This gene is located in the class III region of the human major histocompatibility complex. Alternative splicing results in two transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
283 residues, UniProt reviewed canonical sequence.
>Q99943|AGPAT1
1 MDLWPGAWML LLLLFLLLLF LLPTLWFCSP SAKYFFKMAF YNGWILFLAV LAIPVCAVRG
61 RNVENMKILR LMLLHIKYLY GIRVEVRGAH HFPPSQPYVV VSNHQSSLDL LGMMEVLPGR
121 CVPIAKRELL WAGSAGLACW LAGVIFIDRK RTGDAISVMS EVAQTLLTQD VRVWVFPEGT
181 RNHNGSMLPF KRGAFHLAVQ AQVPIVPIVM SSYQDFYCKK ERRFTSGQCQ VRVLPPVPTE
241 GLTPDDVPAL ADRVRHSMLT VFREISTDGR GGGDYLKKPG GGGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AGPAT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 92 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 92 nTPM
- testis: 77 nTPM
- hippocampal formation: 74 nTPM
- basal ganglia: 73 nTPM
- amygdala: 68 nTPM
- hypothalamus: 66 nTPM
Single-cell type
- other brain neurons: 25 nCPM
- brain inhibitory neurons: 23 nCPM
- oligodendrocytes: 22 nCPM
- ependymal cells: 20 nCPM
- oligodendrocyte progenitor cells: 19 nCPM
- brain excitatory neurons: 18 nCPM
Immune cell
- eosinophil: 13 nTPM
- plasmacytoid DC: 12 nTPM
- myeloid DC: 9.4 nTPM
- neutrophil: 9.4 nTPM
- NK-cell: 8.7 nTPM
- memory CD8 T-cell: 8.6 nTPM
Brain region
- hypothalamus: 65 nTPM
- midbrain: 24 nTPM
- cerebral cortex: 22 nTPM
- white matter: 11 nTPM
- pons: 9.7 nTPM
- basal ganglia: 8.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 2.61
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- CDP-diacylglycerol biosynthetic process
- phosphatidic acid biosynthetic process
- phospholipid metabolic process
- positive regulation of cytokine production
- positive regulation of cytokine-mediated signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AGPAT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AGPAT1 as an antibody target. Whether an autoantibody or antibody against AGPAT1 could matter depends on whether native AGPAT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AGPAT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AGPAT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...